The market could reach an ‘investable’ bottom after analysts cut earnings estimates, Jim Cramer says

The market could reach an ‘investable’ bottom after analysts cut earnings estimates, Jim Cramer says


CNBC’s Jim Cramer on Thursday said that a possible upcoming slew of earnings estimate cuts from analysts could create a sell-off and an opportunity for investors to do some buying.

“Over the next few weeks, before earnings season gets rolling, I expect the analysts to hit us with some preemptive estimate cuts while more companies hit us with negative preannouncements,” he said.

“That’s going to be bad for the averages, but once the sell-off hits and we get over the estimate cuts for 2022 and 2023, that’s it. That’s when we will have not a tradeable bottom like this one, but an investable one,” he added.

The “Mad Money” host’s comments come after a turbulent earnings season roiled by inflation saw companies falling short of Wall Street expectations.

Cramer said that he believes analysts’ consensus earnings estimates for the stocks in the S&P 500 are too high, and they need to come down because markets don’t bottom unless bad news is baked into stock prices.

“They’re predicting 8% growth, followed by 11% next year. I find that hard to believe. Eight percent to eleven percent earnings growth is basically what you’d expect in an average year,” he said.

He pointed out that there have been several companies in recent weeks that reported great quarters but disappointing guidance.

“You had these really great quarters, but they are saying things are getting weaker. People like them because they think the estimate cuts are finally done. I’m not sure,” he said.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

Novo Nordisk CEO sees 15 million-patient opportunity in Medicare coverage for obesity drugs
Business

Novo Nordisk CEO sees 15 million-patient opportunity in Medicare coverage for obesity drugs

Novo Nordisk CEO Mike Doustdar. CNBC Novo Nordisk CEO Mike Doustdar on Wednesday said the company is aiming to capture around 15 million new patients, at least initially, when Medicare starts covering obesity treatments for the first time later this year. Around 67 million Americans are covered by Medicare, but “when you take a look […]

Read More
Scripps launches cost cutting, AI integration in latest effort to generate earnings growth
Business

Scripps launches cost cutting, AI integration in latest effort to generate earnings growth

FILE PHOTO: E.W. Scripps Co. signage is displayed on a monitor on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Friday, June 3, 2016. Michael Nagle | Bloomberg | Getty Images E.W. Scripps is setting into motion what it calls a transformation plan for the broadcast station company — […]

Read More
Property Play: Delinquencies in commercial mortgage-backed securities are on the rise. Here’s what’s happening
Business

Property Play: Delinquencies in commercial mortgage-backed securities are on the rise. Here’s what’s happening

Key Points Delinquencies in commercial mortgage-backed securities rose again in January, up 17 basis points from December to 7.47%, according to Trepp. The increase was driven by the beleaguered office sector, which has a lot of distressed properties to work through but is seeing improvements in fundamentals. The rate increase was driven by two exceptionally […]

Read More